Cargando…

Predicting risk of malignancy in subgroups of B3 breast lesions

Detalles Bibliográficos
Autores principales:	Forester, ND, Brotherton, M, Wason, A-M
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2012
Materias:	Poster Presentation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3542672/ http://dx.doi.org/10.1186/bcr3312

Ejemplares similares

Can mammographic features predict invasive carcinoma at screening assessment?
por: Forester, ND, et al.
Publicado: (2011)

PB.35: Comparison of large-bore vacuum-assisted biopsy and surgical diagnostic excision biopsy in B3 breast lesions
por: Tang, AH, et al.
Publicado: (2013)

Large-bore vacuum-assisted biopsy of axillary lymphadenopathy
por: Forester, ND, et al.
Publicado: (2011)

What is involved in a comprehensive breast MRI service? Implications for service provision
por: Forester, ND, et al.
Publicado: (2010)

Annual screening of moderate-risk women: a review of 10 years experience within the NHS Breast Screening Programme
por: Forester, ND, et al.
Publicado: (2012)

PB.7. Large-volume biopsy for B3 lesions without atypia: is once enough?
por: Forester, N
Publicado: (2014)

Preliminary assessment of ShearWave™ elastography features in predicting breast lesion malignancy
por: Cosgrove, DO, et al.
Publicado: (2010)

Breast screening with magnetic resonance imaging in high-risk women
por: McLean, L, et al.
Publicado: (2012)

PB.27. Breast screening with MRI in high-risk women
por: Howarth, D, et al.
Publicado: (2014)

Value of diffusion-weighted imaging in differentiating benign from malignant breast lesions
por: Stijven, S, et al.
Publicado: (2009)

Usefulness of magnetic resonance imaging in benign and malignant breast lesions: a pictorial review
por: Stahnke, M, et al.
Publicado: (2006)

The 3.5-year to 13.5-year follow up of 137 lesions of uncertain malignant potential (B3 lesions) diagnosed by vacuum-assisted biopsy alone
por: Mullin, Karen, et al.
Publicado: (2015)

Use of MRI to predict response following neoadjuvant chemotherapy for breast cancer: how accurately can it guide surgical choice?
por: Tan, Sue, et al.
Publicado: (2015)

Relative time-intensity curve: a new method to differentiate benign and malignant lesions on breast MRI
por: Sherif, H, et al.
Publicado: (2014)

PB.32: Does vacuum-assisted biopsy decrease the B3 rate in stereotactic biopsy of breast lesions?
por: Seaton, T, et al.
Publicado: (2013)

Comparison of 1.5T and 3T in assessment of suspicious breast lesions
por: Ragupathy, SK Arcot, et al.
Publicado: (2010)

Description of the localized scleroderma subgroup of CARRAnet
por: Wu, Eveline, et al.
Publicado: (2012)

R3 breast lesions - are we categorising and managing them correctly?
por: Tahir, N, et al.
Publicado: (2009)

Molecular and clinical analyses of HTLV-1 subgroups associated with the risk of developing HAM/TSP.
por: Saito, Mineki, et al.
Publicado: (2015)

Negative predictive value for atypia and malignancy of 14-gauge core biopsy of breast papillomas
por: Mataka, GT, et al.
Publicado: (2010)

Association between INADL genetic variant and a subgroup with high risk for TMD in the OPPERA study
por: Smith, Shad B, et al.
Publicado: (2014)

Breast lesion localisation wires: a change in practice
por: Pavis, AJ, et al.
Publicado: (2006)

Haematoma-directed ultrasound guidewire localisation of breast lesions
por: Lee, CM, et al.
Publicado: (2009)

Subgroup analysis of the lipid infusion and patient outcomes in sepsis trial (LIPOS) reveals benefit in a subgroup not treated with stress replacement doses of corticosteroids
por: Parker, TS, et al.
Publicado: (2014)

Role of large volume 'mammotome' biopsy in the management of screen-detected radial scars
por: Rajan, S, et al.
Publicado: (2009)

Handheld ultrasound-guided 20 mm basket Intact breast lesion excision system biopsy for excision of benign breast lesions
por: Lowes, Simon, et al.
Publicado: (2015)

Does a second image-guided biopsy contribute to the management of B3 lesions?
por: Juttla, JK, et al.
Publicado: (2010)

Efficacy of intra-operative wire localisation of breast lesions using ultrasound
por: Raghavendra, GKG, et al.
Publicado: (2009)

A comparison of bayesian adaptive randomization and multi-stage designs for multi-arm clinical trials
por: Wason, James, et al.
Publicado: (2013)

Use of an embedded, micro-randomised trial to investigate non-compliance in telehealth trials
por: Law, Lisa, et al.
Publicado: (2015)

Correlation of preoperative ultrasound and mammographic measurement of malignant breast masses with operative histology
por: Mansi, M, et al.
Publicado: (2010)

Improving phase ii oncology trial using best observed RECIST response as an endpoint by modelling continuous tumour measurements
por: Lin, Chien-Ju, et al.
Publicado: (2015)

Vacuum-assisted core biopsy of B3 lesions showing atypia on needle core biopsy: a worthwhile exercise?
por: Al-Attar, M, et al.
Publicado: (2010)

Can we predict the likelihood of malignancy in mammographically indeterminate microcalcification?
por: Khan, AN, et al.
Publicado: (2009)

PB.31: B3 lesions and vacuum-assisted biopsy: a national survey to gauge current practice
por: Strachan, CL, et al.
Publicado: (2013)

Underestimation of invasive malignancy on conventional core biopsy of breast
por: Rengabashyam, B, et al.
Publicado: (2009)

Impact of three dimensional tomosynthesis on the detection and diagnosis of breast lesions
por: Mansour, Sahar, et al.
Publicado: (2014)

Effect of clarithromycin in patients with Gram-negative sepsis: subgroup analysis of a randomized trial
por: Giamarellos-Bourboulis, E, et al.
Publicado: (2014)

Revisiting the multi-armed bandit model for the optimal design of clinical trials: benefits and drawbacks
por: Villar, Sofia S, et al.
Publicado: (2013)

Stepped-wedge cluster randomised trials: where, when and why?
por: Grayling, Michael, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_20rp200vq5uginpfotberivief